Health ❯ Medicine ❯ Pharmaceuticals

Drug Approval

Leucovorin Wegovy Zepbound Chronic Graft-Versus-Host Disease FDA Regulations Iloprost Chronic Obstructive Pulmonary Disease Alzheimer's Disease Obstructive Sleep Apnea Lupus Nephritis FDA FDA Decisions Mifepristone FDA Advisory Committee Alzheimer's Treatment Novel Medicine

FDA Approves Leucovorin for Ultra-Rare FOLR1 Folate Disorder, Declines Autism Indication

The decision follows an agency review that judged the autism evidence insufficient.

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

FDA Clears Second Generic Mifepristone as White House Cites Legal Duty

FDA Backs Leucovorin for Cerebral Folate Deficiency as White House Promotes Autism Use